Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Cobicistat-boosted Atazanavir vs Ritonavir-boosted Atazanavir in HIV-1
NCT00892437Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- May 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cobicistat in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started May 2009; status: completed.
02
Drugs
cobicistat
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00892437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00892437.